Cite
Straightforward Glycoengineering Approach to Site-Specific Antibody–Pyrrolobenzodiazepine Conjugates
MLA
Binyam Bezabeh, et al. Straightforward Glycoengineering Approach to Site-Specific Antibody–Pyrrolobenzodiazepine Conjugates. Sept. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....17a05cdfcb2e9de804b5da849e8a6140&authtype=sso&custid=ns315887.
APA
Binyam Bezabeh, Cui Chen, Dorin Toader, Luke Masterson, Pamela Thompson, Ryan Fleming, Herren Wu, Shenlan Mao, Changshou Gao, Jia Lin, Ian Hutchinson, Ebele Ezeadi, Philip Howard, Haihong Zhong, & Nazzareno Dimasi. (2016). Straightforward Glycoengineering Approach to Site-Specific Antibody–Pyrrolobenzodiazepine Conjugates.
Chicago
Binyam Bezabeh, Cui Chen, Dorin Toader, Luke Masterson, Pamela Thompson, Ryan Fleming, Herren Wu, et al. 2016. “Straightforward Glycoengineering Approach to Site-Specific Antibody–Pyrrolobenzodiazepine Conjugates,” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....17a05cdfcb2e9de804b5da849e8a6140&authtype=sso&custid=ns315887.